To investigate the clinical relevance of FUT4 and Sp1, PBMCs from 50 AML patients were isolated to directly compare FUT4 and Sp1 levels in paired CD34 + CD38- LSCs and non-LSCs (the rest cells). This evidence concerns the gene CD38 and acute myeloid leukemia.